Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.55 -0.08 (-0.31%)

Official Closing Price Updated: 7:00 PM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

How to Recession-Proof Your Retirement Before the Second Half of 2026 ↗

Today 13:59 EDT

You should consider these strategies if you can't afford to wait out another market crash.

Via The Motley Fool

3 Dividend Stocks to Buy and Hold Forever ↗

Today 3:20 EDT

These aren't the most exciting businesses, but they have a lot to offer to long-term investors.

Via The Motley Fool

Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks ↗

June 01, 2026

Bristol Myers Squibb has an attractive 4.4% yield, and its 16x P/E is below the pharma average of 24x.

Via The Motley Fool

Topics Intellectual Property

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 01, 2026

AbbVie and Pfizer chart distinct paths in revenue growth, risk, and valuation. Explore how their financials and strategies stack up for investors this year.

Via The Motley Fool

Topics Intellectual Property

CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking ↗

June 01, 2026

This little-discussed pipeline program could prove to be a big success.

Via The Motley Fool

Is Pfizer the Perfect Stock to Own with Kevin Warsh Heading the Fed? ↗

June 01, 2026

Pfizer could attract investors if Warsh's "regime change" at the Fed leads to market turbulence.

Via The Motley Fool

Topics Economy

1 Healthcare Stock with Promising Prospects and 2 We Find Risky

June 01, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such a...

Via StockStory

3 Cash-Producing Stocks Worth Your Attention

June 01, 2026

Businesses with strong free cash flow tend to be more adaptable and resilient. Some of these companies shine bright by using their cash wisely to strengthen ...

Via StockStory

Is Pfizer Stock a "Value Trap" or a Generational Opportunity? ↗

May 31, 2026

Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.

Via The Motley Fool

Topics Intellectual Property

How S&P 500 Giant Pfizer Is Tackling Hard-To-Treat Cancers ↗

May 31, 2026

Pfizer said Sunday its Braftovi-tied regimen nearly doubled the time colon cancer patients lived without getting sicker.

Via Investor's Business Daily

Topics Stocks

Thriving in the Age of Overwhelm ↗

May 30, 2026

Why do so many people feel overwhelmed right now? And what can investors do about it?

Via The Motley Fool

Why Wall Street Is Dead Wrong About This Popular Stock ↗

May 30, 2026

Often, investors and Wall Street analysts focus on the short term and don't give enough thought to the long term.

Via The Motley Fool

Topics Intellectual Property

Addiction Treatment Market Size, Demand, Growth By 2035 ↗

May 29, 2026

The most recent research report on the "Addiction Treatment Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts

Via Talk Markets

Topics Economy

Pfizer Strikes Up To $10.5 Billion Deal With China's Innovent Biologics To Develop Next-Gen Cancer Therapies ↗

May 29, 2026

Pfizer and Innovent Biologics sign a $10.5 billion cancer drug deal to develop 12 oncology programs globally.

Via Benzinga

Rituxan (rituximab) Drug Market Size, Share, Industry Growth By 2035 ↗

May 28, 2026

The most recent research report on the "Rituxan (rituximab) Drug Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic fore

Via Talk Markets

Topics Economy

Drugs for Oral Mucositis Market Size, Report Growth By 2035 ↗

May 28, 2026

The most recent research report on the "Drugs for Oral Mucositis Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic fore

Via Talk Markets

Topics Economy

1 Stock Under $50 with Solid Fundamentals and 2 We Ignore

May 28, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...

Via StockStory

Topics Energy

D-Wave Quantum vs. IonQ: Which Quantum Computing Stock Is a Better Buy in 2026? ↗

May 26, 2026

Explore how two quantum innovators stack up on customer reach, financial health, and risk as they race for commercial leadership in a fast-evolving sector.

Via The Motley Fool

3 Dividend Stocks Yielding Above 5% to Scoop Up Now

May 26, 2026

These three dividend stocks combine strong yields with resilient businesses.

Via Barchart.com

Topics Artificial Intelligence

3 Blue Chip Dividend Stocks to Buy in June as the Dow Jones Industrial Average Turns 130 ↗

May 26, 2026

The Dow is no longer dominated by industrial, energy, manufacturing, and consumer goods companies.

Via The Motley Fool

Topics Artificial Intelligence Economy Stocks

This Healthcare Stock With 6%-Plus Yield: Is the Dividend Safe? ↗

May 25, 2026

The payout ratio is over 100% for this high-yield healthcare giant, but don't run for the hills just yet.

Via The Motley Fool

Topics Intellectual Property

Why 1 Wall Street Analyst Thinks Pfizer (PFE) Stock Could Soar 38% ↗

May 25, 2026

As with other pharma companies, much rides on Pfizer's pipeline; it has many promising formulations in late-stage trials.

Via The Motley Fool

Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know. ↗

May 25, 2026

The pharma giant is taking steps to expand its portfolio.

Via The Motley Fool

Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q1

May 24, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, incl...

Via StockStory

Topics Artificial Intelligence Intellectual Property

What's the Better Dividend Stock Today: AbbVie or Pfizer? ↗

May 24, 2026

These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.

Via The Motley Fool

Topics Intellectual Property

Is Relay Therapeutics a Buy After Promising Trial Results? ↗

May 22, 2026

Relay Therapeutics, a clinical-stage biotech, is getting a boost after positive trial news for its lead therapy.

Via The Motley Fool

The Most Important Healthcare Stock You're Not Watching ↗

May 22, 2026

Down more than 50% from its 2021 highs, this pharmaceutical giant has been forgotten by Wall Street.

Via The Motley Fool

Topics Intellectual Property

Pediatrics Medicine Market Size, Industry Report By 2035 ↗

May 22, 2026

The most recent research report on the "Pediatrics Medicine Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts

Via Talk Markets

Topics Economy

Prediction: Alphabet Will Join the $5 Trillion Club and the Dow Jones Industrial Average in June ↗

May 22, 2026

Honeywell is spinning off its aerospace segment, which could trigger a shake-up in the Dow Jones Industrial Average this summer.

Via The Motley Fool

Topics Stocks

May 22, 2026

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.